North East and North Cumbria (NENC) ICB are seeking system-wide views on adoption of a NICE 30-day TA for deuruxolitinib for severe alopecia areata.
This consultation is open for 2 weeks and closes at 5pm on Thursday 30th July 2026. Visit the consultation page here.